INTELLIGENT BIO SOLUTIONS INC. Repayments of Convertible Debt
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Repayments of Convertible Debt of $150.99 thousand for the 12-month period ending 2020-06-30, per its 10-K filed 2021-09-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2021-09-16
- INTELLIGENT BIO SOLUTIONS INC. repayments of convertible debt for fiscal 2020 was $150.99K.
| Period end | Repayments of Convertible Debt 12 month |
|---|---|
| 2020-06-30 | $150.99K 10-K · filed 2021-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |